Response alone does not define optimal bridging before brexucabtagene autoleucel in mantle cell lymphoma. Zhang M, Chen Y. Br J Haematol 2026 Jun 14. doi: 10.1111/bjh.70615.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang M, Chen Y. Response alone does not define optimal bridging before brexucabtagene autoleucel in mantle cell lymphoma. Br J Haematol 2026 Jun 14. doi: 10.1111/bjh.70615.
PMID: 42289300